Kiora Total Assets from 2010 to 2024

KPRX Stock

USD 3.31 0.11 3.22%

Kiora Pharmaceuticals Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets will likely drop to about 11.7 M in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2013-12-31

Previous Quarter

40.8 M

Current Value

38.5 M

Quarterly Volatility

9.4 M

Yuan Drop

Covid

Check Kiora Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Kiora Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 84.2 K, Selling General Administrative of 4.8 M or Other Operating Expenses of 10.3 M, as well as many indicators such as Price To Sales Ratio of 16 K, Dividend Yield of 0.0 or PTB Ratio of 0.43. Kiora financial statements analysis is a perfect complement when working with Kiora Pharmaceuticals Valuation or Volatility modules.

Check out the analysis of Kiora Pharmaceuticals Correlation against competitors.

For more information on how to buy Kiora Stock please use our How to Invest in Kiora Pharmaceuticals guide.

Latest Kiora Pharmaceuticals' Total Assets Growth Pattern

Below is the plot of the Total Assets of Kiora Pharmaceuticals over the last few years. Total assets refers to the total amount of Kiora Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Kiora Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Kiora Pharmaceuticals' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Kiora Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 13.71 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Kiora Total Assets Regression Statistics

	Arithmetic Mean	9,626,747
	Geometric Mean	6,600,794
	Coefficient Of Variation	65.41
	Mean Deviation	5,216,792
	Median	10,112,514
	Standard Deviation	6,296,851
	Sample Variance	39.7T
	Range	18M
	R-Value	0.84
	Mean Square Error	12.4T
	R-Squared	0.71
	Significance	0.000081
	Slope	1,186,045
	Total Sum of Squares	555.1T

Kiora Total Assets History

	2024	11.7 M
	2023	13.7 M
	2022	18.7 M
	2021	18.1 M
	2020	15.2 M
	2019	10.1 M
	2018	14.3 M

Other Fundumenentals of Kiora Pharmaceuticals

Intangibles To Total Assets

Kiora Pharmaceuticals Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Current Deferred Revenue	Good Will	Intangible Assets	Net Tangible Assets	Deferred Long Term Liab	Net Invested Capital	Net Working Capital	Property Plant Equipment	Capital Stock	Long Term Debt	Short Long Term Debt
Total Assets		0.93	-0.68	-0.82	0.31	0.43	-0.87	0.76	-0.48	0.49	0.47	-0.73	0.61	0.74	0.67	0.79	0.77	0.52	-0.66	-0.17	-0.17
Total Stockholder Equity	0.93		-0.69	-0.79	0.3	0.47	-0.99	0.76	-0.55	0.51	0.42	-0.69	0.43	0.7	0.53	0.73	0.71	0.43	-0.63	-0.26	-0.26
Net Debt	-0.68	-0.69		0.31	-0.15	-0.14	0.69	-0.95	0.67	-0.61	-0.45	0.31	-0.03	-0.28	-0.06	-0.34	-0.38	-0.16	0.07	-0.11	-0.11
Retained Earnings	-0.82	-0.79	0.31		-0.11	-0.77	0.7	-0.48	0.32	-0.26	-0.34	0.91	-0.7	-0.92	-0.78	-0.83	-0.83	-0.82	0.84	0.64	0.64
Accounts Payable	0.31	0.3	-0.15	-0.11		0.01	-0.29	0.18	-0.02	-0.05	0.37	0.11	0.21	-0.13	0.05	-0.06	-0.15	0.0	-0.02	0.18	0.18
Net Receivables	0.43	0.47	-0.14	-0.77	0.01		-0.41	0.35	-0.22	-0.03	0.09	-0.67	0.61	0.69	0.61	0.47	0.47	0.88	-0.57	-0.81	-0.81
Total Liab	-0.87	-0.99	0.69	0.7	-0.29	-0.41		-0.74	0.55	-0.5	-0.35	0.63	-0.34	-0.64	-0.46	-0.67	-0.66	-0.32	0.58	0.19	0.19
Total Current Assets	0.76	0.76	-0.95	-0.48	0.18	0.35	-0.74		-0.53	0.61	0.48	-0.46	0.16	0.44	0.18	0.44	0.49	0.36	-0.19	-0.07	-0.07
Short Term Debt	-0.48	-0.55	0.67	0.32	-0.02	-0.22	0.55	-0.53		-0.3	-0.29	0.28	-0.13	-0.29	-0.18	-0.29	-0.29	-0.16	0.24	0.14	0.14
Common Stock	0.49	0.51	-0.61	-0.26	-0.05	-0.03	-0.5	0.61	-0.3		0.37	-0.3	-0.2	0.34	-0.05	0.37	0.41	-0.01	0.11	-0.04	-0.04
Current Deferred Revenue	0.47	0.42	-0.45	-0.34	0.37	0.09	-0.35	0.48	-0.29	0.37		-0.05	0.02	0.06	0.02	0.02	0.02	0.1	-0.03	-0.17	-0.17
Good Will	-0.73	-0.69	0.31	0.91	0.11	-0.67	0.63	-0.46	0.28	-0.3	-0.05		-0.59	-0.99	-0.71	-0.93	-0.96	-0.79	0.83	0.51	0.51
Intangible Assets	0.61	0.43	-0.03	-0.7	0.21	0.61	-0.34	0.16	-0.13	-0.2	0.02	-0.59		0.61	0.94	0.62	0.53	0.72	-0.74	-0.31	-0.31
Net Tangible Assets	0.74	0.7	-0.28	-0.92	-0.13	0.69	-0.64	0.44	-0.29	0.34	0.06	-0.99	0.61		0.74	0.94	0.96	0.78	-0.82	-0.56	-0.56
Deferred Long Term Liab	0.67	0.53	-0.06	-0.78	0.05	0.61	-0.46	0.18	-0.18	-0.05	0.02	-0.71	0.94	0.74		0.71	0.67	0.71	-0.81	-0.35	-0.35
Net Invested Capital	0.79	0.73	-0.34	-0.83	-0.06	0.47	-0.67	0.44	-0.29	0.37	0.02	-0.93	0.62	0.94	0.71		0.97	0.59	-0.83	-0.3	-0.3
Net Working Capital	0.77	0.71	-0.38	-0.83	-0.15	0.47	-0.66	0.49	-0.29	0.41	0.02	-0.96	0.53	0.96	0.67	0.97		0.63	-0.79	-0.32	-0.32
Property Plant Equipment	0.52	0.43	-0.16	-0.82	0.0	0.88	-0.32	0.36	-0.16	-0.01	0.1	-0.79	0.72	0.78	0.71	0.59	0.63		-0.62	-0.69	-0.69
Capital Stock	-0.66	-0.63	0.07	0.84	-0.02	-0.57	0.58	-0.19	0.24	0.11	-0.03	0.83	-0.74	-0.82	-0.81	-0.83	-0.79	-0.62		0.4	0.4
Long Term Debt	-0.17	-0.26	-0.11	0.64	0.18	-0.81	0.19	-0.07	0.14	-0.04	-0.17	0.51	-0.31	-0.56	-0.35	-0.3	-0.32	-0.69	0.4		1.0
Short Long Term Debt	-0.17	-0.26	-0.11	0.64	0.18	-0.81	0.19	-0.07	0.14	-0.04	-0.17	0.51	-0.31	-0.56	-0.35	-0.3	-0.32	-0.69	0.4	1.0

Click cells to compare fundamentals

About Kiora Pharmaceuticals Financial Statements

Kiora Pharmaceuticals investors use historical fundamental indicators, such as Kiora Pharmaceuticals' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Kiora Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	13.7 M	11.7 M
Intangibles To Total Assets	0.64	0.45

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

Additional Tools for Kiora Stock Analysis

When running Kiora Pharmaceuticals' price analysis, check to measure Kiora Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kiora Pharmaceuticals is operating at the current time. Most of Kiora Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kiora Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kiora Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kiora Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC